Alessia Locatelli Selected Research

ozarelix

9/2010

Ozarelix, a fourth generation GnRH antagonist, induces apoptosis in hormone refractory androgen receptor negative prostate cancer cells modulating expression and activity of death receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessia Locatelli Research Topics

Disease

4	Neoplasms (Cancer) 04/2012 - 09/2010
3	Breast Neoplasms (Breast Cancer) 07/2013 - 09/2011
3	Neoplasm Metastasis (Metastasis) 07/2013 - 09/2010
2	Carcinogenesis 04/2012 - 06/2011
2	Prostatic Neoplasms (Prostate Cancer) 09/2010 - 09/2010

Drug/Important Bio-Agent (IBA)

2	Hormones (Hormone)IBA 04/2012 - 09/2010
2	Phosphotransferases (Kinase)IBA 04/2012 - 09/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2012 - 09/2011
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2012 - 06/2011
2	Androgen Receptors (Androgen Receptor)IBA 09/2010 - 09/2010
2	AndrogensIBA 09/2010 - 09/2010
1	Endothelin-1 (Endothelin 1)IBA 07/2013
1	NF-kappa B (NF-kB)IBA 07/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2012
1	Peptides (Polypeptides)IBA 04/2012
1	tyrosine receptor (receptor, tyrosine)IBA 04/2012
1	N- phenylacetoaminomethylene- DL- p- nitrophenylalanine (A 101)IBA 04/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2011
1	Epidermal Growth Factor (EGF)IBA 09/2011
1	p38 Mitogen-Activated Protein KinasesIBA 09/2011
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2010
1	ozarelixIBA 09/2010
1	Death Domain ReceptorsIBA 09/2010
1	Estrogen Receptor betaIBA 09/2010
1	LuciferasesIBA 09/2010